Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression. International Journal of Cell and Biomedical Science, v. 1, n. 2, p. 65–69, 30 Sep.2022.